Search - tctmd.com

Displaying 81 - 100 of 226

Sort: Relevancy | Date

News Industry News

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

October 15, 2020

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

News Daily News

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

September 23, 2020

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

News Daily News

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

July 22, 2020

High TEE Injury Rate in Structural Heart Interventions Warrants Caution

News Daily News

High TEE Injury Rate in Structural Heart Interventions Warrants Caution

Yael L. Maxwell

June 24, 2020

PINNACLE FLX: New-Generation Watchman Has High Closure Rates, Good Safety

News Conference News HRS 2020

PINNACLE FLX: New-Generation Watchman Has High Closure Rates, Good Safety

May 15, 2020

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

News Daily News

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

April 13, 2020

March 2020 News Roundup

News Opinion CV Team Dispatch

March 2020 News Roundup

March 12, 2020

Embolization Coils May Be an Option for Leaks After LAA Occlusion

News Daily News

Embolization Coils May Be an Option for Leaks After LAA Occlusion

January 15, 2020

Contentious Medical Device Tax May Soon Be Gone

News Daily News

Contentious Medical Device Tax May Soon Be Gone for Good

Yael L. Maxwell

December 20, 2019

Long-term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries

Presentation

Long-term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries

December 02, 2019

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

Presentation Controversies and Advances 2019

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

Presenter: Tarun Chakravarty

November 15, 2019

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

News Daily News

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

November 01, 2019

Expert Consensus Aims to Promote Cardiac CT Use in Preprocedural LAA Occlusion

News Daily News

Expert Consensus Aims to Promote Cardiac CT Use in Preprocedural LAA Occlusion

Yael L. Maxwell

November 01, 2019

TCTMD’s Top 10 Most Popular Stories for October 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

October 31, 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

October 04, 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

September 11, 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

September 10, 2019

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

News Daily News

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

Michael O'Riordan

August 19, 2019

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

News Daily News

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

August 16, 2019

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

News Opinion Fellow Talk

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Yashasvi Chugh, MD

August 05, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.